OneSource Specialty Pharma LimitedNSE: ONESOURCE

Press Release Jun 11 2025

· Issued by OneSource Specialty Pharma Limited

Filed with NSE · · 3 pages · English

Summary by 6ix AI

The collaboration aims to enhance Xbrane's supply chain and accelerate regulatory approvals for OneSource's biologics facility. OneSource has also participated in Xbrane's recent funding round, indicating a long-term alignment between the companies.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

OneSource Specialty Pharma Limited on 6ix

Earlier from OneSource Specialty Pharma

Later from OneSource Specialty Pharma

All OneSource Specialty Pharma news releases